International Journal of Infection

Published by: Kowsar

Elimination of Hepatitis C Virus Infection Among Hemodialysis Patients Will Be Possible If All Patients Undergo Treatment

Seyed Moayed Alavian 1 , *
Author Information
1 Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, Iran
Article information
  • International Journal of Infection: October 2018, 5 (4); e69025
  • Published Online: October 13, 2018
  • Article Type: Letter
  • Received: April 2, 2018
  • Accepted: October 7, 2018
  • DOI: 10.5812/iji.69025

To Cite: Alavian S M. Elimination of Hepatitis C Virus Infection Among Hemodialysis Patients Will Be Possible If All Patients Undergo Treatment, Int J Infect. 2018 ; 5(4):e69025. doi: 10.5812/iji.69025.

Copyright © 2018, International Journal of Infection. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
References
  • 1. Ibrahim NMR, Sidiq Mohammed Saleem Z, R Hussein N. The prevalence of HIV, HCV, and HBV among hemodialysis patients attending duhok hemodialysis center. Int J Infect. 2017;5(1). e63246. doi: 10.5812/iji.63246.
  • 2. Kargar Kheirabad A, Bahri F, Kargar M, Ghasemzadeh I. Hepatitis C and G virus infection prevalence among hemodialysis patients and associated risk factors in the Hormozgan province of Southern Iran. Hepat Mon. 2016;16(10). e40375. doi: 10.5812/hepatmon.40375. [PubMed: 27882069]. [PubMed Central: PMC5111419].
  • 3. Ashkani-Esfahani S, Alavian SM, Salehi-Marzijarani M. Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis. World J Gastroenterol. 2017;23(1):151-66. doi: 10.3748/wjg.v23.i1.151. [PubMed: 28104991]. [PubMed Central: PMC5221279].
  • 4. Fabrizi F, Maria Donato F, Messa P. Efficacy and safety of reinforced versus standard vaccine schedule towards hepatitis b in chronic kidney disease: A systematic review and meta-analysis. Hepat Mon. 2017;17(7). e44179. doi: 10.5812/hepatmon.44179.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments